← Back to headlines
Dutch Researchers: Too Few Breast Cancer Patients Receive Necessary Gene Test
New research from the Dutch Cancer Institute (IKNL) and Utrecht University suggests that an insufficient number of breast cancer patients are receiving a crucial gene test. This test helps determine whether chemotherapy is necessary for their treatment, potentially leading to overtreatment or undertreatment.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
